Skip to content
March 28, 2024

Equity.Guru

Investment information for the new generation

Search

ADAP.Q

Adaptimmune Therapeutics (ADAP.Q) announced today that it has entered into a strategic collaboration and license agreement with Genentech, a member of the Roche Group, to develop and commercialize allogenic…